Journal Journal: Drug patents threatening cheap drugs
This was a story I tried to submit but was rejected by Slashdot's editorial staff. Not grousing, saving my composition here for posterity, as I do with other of my rejected stories.
Loan-department manager: "There isn't any fine print. At these interest rates, we don't need it."
